Lu et al. [115] reported that SNHG12 acts as a sponge for miR-129-5p, therefore leading to elevated expression of MAPK1 and E2F7, which in consequence promotes cell proliferation, suppresses cell apoptosis, and enhances the development of temozolomide resistance in glioblastoma cells. The gene discussed is SNHG12; the disease is glioblastoma.